Cargando…
Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study
Our objective was to assess the safety and efficacy of olaparib in maintenance therapy of BRCA 1-2 mutated, platinum-sensitive, recurrent ovarian carcinoma after the partial or complete response to the second or further lines platinum-based chemotherapy in a real-world setting. We performed a multic...
Autores principales: | Majić, Ana, Miše, Branka Petrić, Matković, Višnja, Belac Lovasić, Ingrid, Katić, Kristina, Canjko, Ivana, Frobe, Ana, Bajić, Žarko, Vrdoljak, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322596/ https://www.ncbi.nlm.nih.gov/pubmed/32655639 http://dx.doi.org/10.1155/2020/6423936 |
Ejemplares similares
-
Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia
por: Čerina, Dora, et al.
Publicado: (2022) -
Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients
por: Čerina, Dora, et al.
Publicado: (2021) -
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice
por: Čerina, Dora, et al.
Publicado: (2021) -
COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
por: Vrdoljak, Eduard, et al.
Publicado: (2021) -
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia
por: Čerina, Dora, et al.
Publicado: (2023)